| Current Price | $87.98 | Mkt Cap | $183.9B |
|---|---|---|---|
| Open | $88.03 | P/E Ratio | 15.67 |
| Prev. Close | $88.46 | Div. (Yield) | $2.01 (2.3%) |
| Daily Range | $87.90 - $88.11 | Volume | 17,499 |
| 52-Wk Range | $69.18 - $99.84 | Avg. Daily Vol. | 1,820,620 |
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
| Current Price | $87.98 | Mkt Cap | $183.9B |
|---|---|---|---|
| Open | $88.03 | P/E Ratio | 15.67 |
| Prev. Close | $88.46 | Div. (Yield) | $2.01 (2.3%) |
| Daily Range | $87.90 - $88.11 | Volume | 17,499 |
| 52-Wk Range | $69.18 - $99.84 | Avg. Daily Vol. | 1,820,620 |
The best Bull and Bear pitches based on recency and number of recommendations.
Dividend, M & A activity, and pipeline.
After a good run in the past couple months, NVS looks poised to underperform the S&P. Not that I think its going to take a fall, more so that the S&P will be playing catchup for the next couple of months while NVS hangs around somewhat.
Read the most recent pitches from players about NVS.
Recs
jbswen
(< 20)
Submitted: 3/27/2020 2:10:51 PM :
Start Price:
$79.17
NYSE:NVS Score:
-11.49
With this epidemic and once the find a cure they are for sure to take off
Recs
TMFAdriaCimino
(56.49)
Submitted: 2/20/2020 4:29:31 AM :
Start Price:
$95.16
NYSE:NVS Score:
-0.45
The flow of newly approved drugs will lift revenue over the long term, making me bullish on the stock.
Recs
TMFmarkprvulovic
(45.87)
Submitted: 10/17/2019 4:21:14 AM :
Start Price:
$82.06
NYSE:NVS Score:
-1.08
Growing revenues among most major drugs, with its top therapy seeing an impressive 23% increase in quarterly revenue. Updated clinical results for breast cancer drug are also highly impressive.
Find the members with the highest scoring picks in NVS.
claygrant1974 (35.33) Score: +114.09
The Score Leader is the player with the highest score across all their picks in NVS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| PurePwnage | 99.47 | 11/27/2009 |
|
5Y | $41.02 | +115.67% | +191.06% | +75.39 | 0 Comment | |
| Bankwatcher1 | 27.69 | 10/7/2008 |
|
NS | $38.28 | +131.06% | +206.42% | +75.35 | 0 Comment | |
| Spelunkin | 96.29 | 11/2/2009 |
|
5Y | $38.67 | +128.75% | +203.00% | +74.25 | 0 Comment | |
| 39272x0 | 96.35 | 12/2/2009 |
|
5Y | $42.06 | +110.31% | +183.53% | +73.22 | 0 Comment | |
| kaChingkaChing | 42.04 | 12/2/2009 |
|
3W | $42.06 | +110.31% | +183.53% | +73.22 | 0 Comment | |
| DiamondDawg | 97.00 | 11/25/2009 |
|
5Y | $41.69 | +112.19% | +183.81% | +71.62 | 0 Comment | |
| TrackDuality | 23.95 | 11/6/2009 |
|
5Y | $39.09 | +126.30% | +196.92% | +70.62 | 0 Comment | |
| 39272x4 | 26.51 | 11/10/2009 |
|
5Y | $39.99 | +121.19% | +188.64% | +67.45 | 0 Comment | |
| triengen | < 20 | 5/25/2011 |
|
5Y | $49.23 | +79.70% | +138.26% | +58.56 | 0 Comment | |
| Okcfirefighter | < 20 | 12/27/2010 |
|
5Y | $45.09 | +96.20% | +151.16% | +54.97 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
